Promore Pharma AB (publ) reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was SEK 7.08 million compared to SEK 8.37 million a year ago. Basic loss per share from continuing operations was SEK 0.12 compared to SEK 0.14 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.15 SEK | -5.30% | -12.80% | -33.12% |
Apr. 11 | PMD Device Solutions AB (OM:PMDS) acquired Coala Life Inc from Coala-Life Group AB for SEK 3.6 million. | CI |
Apr. 09 | PMD Device Solutions to Purchase Coala-Life Group's US Unit | MT |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.12% | 14.36M | |
-2.19% | 103B | |
+1.76% | 95.28B | |
+1.46% | 22.15B | |
-15.72% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.17% | 16.05B | |
+4.74% | 13.68B | |
+36.41% | 12.17B |
- Stock Market
- Equities
- PMDS Stock
- News PMD Device Solutions AB
- Promore Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2023